What is GeneDx Holdings's total equity?

GeneDx Holdings (WGS) reported total equity of $254.12M in Q1 2026.

How has GeneDx Holdings's total equity changed year-over-year?

GeneDx Holdings's total equity decreased by 1.3% year-over-year, from $257.41M to $254.12M.

What is the long-term trend for GeneDx Holdings's total equity?

Over 5 years (2020 to 2025), GeneDx Holdings's total equity has grown at a -1.4% compound annual growth rate (CAGR), from -$330.05M to $308.18M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

GeneDx Holdings WGS Total Equity

Total Equity at other companies

Natera, Inc.NTRA

$1.77B+43.1%

Tempus AI, Inc.TEM

$416.41M+27.7%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Quest DiagnosticsDGX

$7.37B+6.3%

RevvityRVTY

$7.18B-5.9%

Labcorp HoldingsLH

$8.73B+5.1%

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's total equity?: GeneDx Holdings (WGS) reported total equity of $254.12M in Q1 2026.
How has GeneDx Holdings's total equity changed year-over-year?: GeneDx Holdings's total equity decreased by 1.3% year-over-year, from $257.41M to $254.12M.
What is the long-term trend for GeneDx Holdings's total equity?: Over 5 years (2020 to 2025), GeneDx Holdings's total equity has grown at a -1.4% compound annual growth rate (CAGR), from -$330.05M to $308.18M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.